These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9438393
1. Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. De Vita G, Zannini M, Cirafici AM, Melillo RM, Di Lauro R, Fusco A, Santoro M. Cell Growth Differ; 1998 Jan; 9(1):97-103. PubMed ID: 9438393 [Abstract] [Full Text] [Related]
2. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A. Oncogene; 1996 Apr 18; 12(8):1821-6. PubMed ID: 8622903 [Abstract] [Full Text] [Related]
3. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S, Ledent C. Endocrinology; 1996 Jan 18; 137(1):375-8. PubMed ID: 8536638 [Abstract] [Full Text] [Related]
4. Thyroid-specific gene expression is differentially influenced by intracellular glutathione level in FRTL-5 cells. Lonigro R, Donnini D, Fabbro D, Perrella G, Damante G, Ambesi Impiombato FS, Curcio F. Endocrinology; 2000 Mar 18; 141(3):901-9. PubMed ID: 10698164 [Abstract] [Full Text] [Related]
5. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Barone MV, Sepe L, Melillo RM, Mineo A, Santelli G, Monaco C, Castellone MD, Tramontano D, Fusco A, Santoro M. Oncogene; 2001 Oct 25; 20(48):6973-82. PubMed ID: 11704822 [Abstract] [Full Text] [Related]
6. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. Hwang ES, Kim DW, Hwang JH, Jung HS, Suh JM, Park YJ, Chung HK, Song JH, Park KC, Park SH, Yun HJ, Kim JM, Shong M. Mol Endocrinol; 2004 Nov 25; 18(11):2672-84. PubMed ID: 15297606 [Abstract] [Full Text] [Related]
14. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Kambe F, Nomura Y, Okamoto T, Seo H. Mol Endocrinol; 1996 Jul 25; 10(7):801-12. PubMed ID: 8813721 [Abstract] [Full Text] [Related]
15. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A. Clin Cancer Res; 1998 Feb 25; 4(2):287-94. PubMed ID: 9516913 [Abstract] [Full Text] [Related]
16. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Ros P, Rossi DL, Acebrón A, Santisteban P. Biochimie; 1999 Apr 25; 81(4):389-96. PubMed ID: 10401674 [Abstract] [Full Text] [Related]
20. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas. Fluge O, Haugen DR, Akslen LA, Marstad A, Santoro M, Fusco A, Varhaug JE, Lillehaug JR. Oncogene; 2001 Feb 15; 20(7):885-92. PubMed ID: 11314023 [Abstract] [Full Text] [Related] Page: [Next] [New Search]